FDA Recall Open, Classified

DELFIA hCG Kit, In Vitro Diagnostic for the determination of human gonadotropin (hCG) Product Code: A007-101 - Product Usage: Quantitative determination of human gonadotrophin (hCG) in serum.

Recall: Z-1237-2019 · Initiated January 10, 2019

Recall

Recall Number
Z-1237-2019
Event Number
82064
Firm
PerkinElmer Life and Analytical Sciences, Wallac, OY Mustionkatu 6
FEI Number
3002808498
Product Code
JHJ
Status
Open, Classified
Root Cause
Nonconforming Material/Component
Initiated
January 10, 2019
Address
P.O. Box 10, Turku Finland

Description

DELFIA hCG Kit, In Vitro Diagnostic for the determination of human gonadotropin (hCG) Product Code: A007-101 - Product Usage: Quantitative determination of human gonadotrophin (hCG) in serum.

Reason

hCG analyte concentrations may be decreased up to 15- 20% at the lower measuring range of hCG concentrations.

Action

Perkin Elmer initiated notification on January 10, 2018. The Recall Letter delivered to the end customer by email facilitated through the PerkinElmer Technical Support Group. PerkinElmer requires customers to: Inspect DELFIA / AutoDELFIA hCG kit inventory for the affected lots. Review your QC follow-up of the AutoDELFIA hCG assay for potential decrease in the control concentrations. If the control values are within your established acceptance range it is safe to report the results To avoid unnecessary repeat testing of samples, if the control values are out of the acceptance range discontinue use of the DELFIA / AutoDELFIA hCG kit lot and dispose the remaining kits of the lot. Complete the Response Form with the quantity of affected DELFIA / AutoDELFIA hCG kits you have disposed from your inventory

Distribution

Worldwide distribution - US Nationwide distribution. and countries of Austria, Bolivia, UK, Switzerland,Thailand, Finland.

Quantity

31 kits (10 in US, 21 in ROW)